Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 5
2008 8
2009 6
2010 4
2011 2
2012 1
2013 6
2014 1
2015 2
2017 1
2018 1
2019 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Solid form screening--a review.
Aaltonen J, Allesø M, Mirza S, Koradia V, Gordon KC, Rantanen J. Aaltonen J, et al. Eur J Pharm Biopharm. 2009 Jan;71(1):23-37. doi: 10.1016/j.ejpb.2008.07.014. Epub 2008 Jul 31. Eur J Pharm Biopharm. 2009. PMID: 18715549 Review.
Burden of idiopathic inflammatory rheumatic diseases in occupational healthcare: increased absenteeism and healthcare resource utilization.
Ukkola-Vuoti L, Karlsson A, Tuominen S, Lassenius MI, Aaltonen J, Ranta M, Kosunen M, Renlund M, Lehtonen A, Puolakka K. Ukkola-Vuoti L, et al. Among authors: aaltonen j. Scand J Work Environ Health. 2023 Jul 1;49(5):341-349. doi: 10.5271/sjweh.4095. Epub 2023 Apr 24. Scand J Work Environ Health. 2023. PMID: 37096788 Free PMC article.
Taking PAT to the next level.
Ciurczak EW, Ketolainen J, Laitinen R, Aaltonen J, Lindén HH. Ciurczak EW, et al. Among authors: aaltonen j. Eur J Pharm Sci. 2011 Jan 18;42(1-2):1-2. doi: 10.1016/j.ejps.2010.10.009. Epub 2010 Oct 30. Eur J Pharm Sci. 2011. PMID: 21040783
Hyphenated spectroscopy as a polymorph screening tool.
Aaltonen J, Strachan CJ, Pöllänen K, Yliruusi J, Rantanen J. Aaltonen J, et al. J Pharm Biomed Anal. 2007 Jun 28;44(2):477-83. doi: 10.1016/j.jpba.2007.02.009. Epub 2007 Feb 13. J Pharm Biomed Anal. 2007. PMID: 17367979
Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice.
Ylisaukko-Oja T, Torvinen S, Aaltonen J, Nuutinen H, Blomster T, Jussila A, Pajala M, Salminen K, Moilanen V, Hakala K, Kellokumpu M, Toljamo K, Rautiainen H, Kuisma J, Peräaho M, Molander P, Silvennoinen J, Liukkonen V, Henricson H, Tillonen J, Esterinen M, Nielsen C, Hirsi E, Lääne M, Suhonen UM, Vihriälä I, Mäkelä P, Puhto M, Punkkinen J, Sulonen H, Herrala S, Jokelainen J, Tamminen K, Sipponen T. Ylisaukko-Oja T, et al. Among authors: aaltonen j. Biologicals. 2019 Mar;58:50-56. doi: 10.1016/j.biologicals.2019.01.007. Epub 2019 Feb 10. Biologicals. 2019. PMID: 30755369 Clinical Trial.
33 results